Promising strategy for glaucoma cell replacement therapy
Changing blood stem cells into retinal ganglion cells that can migrate to the eye’s retina offers hope for cell replacement therapy.
List view / Grid view
Changing blood stem cells into retinal ganglion cells that can migrate to the eye’s retina offers hope for cell replacement therapy.
US researchers uncover that certain nerve cells that have the capacity to regrow, are necessary for axon regeneration, providing hope for conditions like blindness and paralysis.
The researchers found restoring mitochondrial homeostasis in the diseased neurons could protect the optic nerve cells from being damaged from glaucoma.
Scientists shed light on how genetic architecture in human retina cells determine gene expression, tissue-specific function, and disease phenotype in blinding diseases.
Using X-ray crystallography and cryo-electron microscopy, researchers have elucidated the structure of the SARM1 protein, a target for neurodegeneration.
New research shows that immune cells developed from early exposure to bacteria contribute to vision loss in glaucoma patients...
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma...
Researchers create eye neuron network model to study retinal diseases, possible treatment options...
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.
Researchers have identified a new neuroprotective factor that has the potential to help people suffering from glaucoma...
Nemus Bioscience announced that THC derived from NB1111 achieved significant tissue concentrations in multiple compartments of the eye...
Researchers at the University of Rochester Medical Centre have developed a new imaging technique to better assess eye health and potential disease.